CPMC Holdings ROE 2024

CPMC Holdings Aktienanalyse

What does CPMC Holdings do?

CPMC Holdings Ltd is a significant Chinese company specializing in the manufacturing of pharmaceutical products and medical devices. It was founded in Shanghai in 2001 and has been listed on the Hong Kong Stock Exchange since 2004. The company started as a joint venture between Shanghai Pharmaceuticals Holding Co. Ltd. and TPG Capital, a private US investment company. In the early 2000s, the Chinese pharmaceutical market was still relatively undeveloped, and there was a high demand for quality and innovation in this area. CPMC sought to fill this niche and quickly became one of the industry-leading companies in China. Today, CPMC is a giant conglomerate with over 150 subsidiaries, over 50,000 employees, and an annual revenue of over USD 10 billion. It is divided into four main business segments: Pharmaceuticals, Medical Devices, Biotechnology, and Services. In the pharmaceutical segment, CPMC is involved in the manufacturing of oncology products, infusion solutions, antibiotics, and specialized medications. The company also produces generic versions of well-known drugs and has partnerships with international companies such as Pfizer, AstraZeneca, and GlaxoSmithKline. CPMC's medical devices range from endoscopes and ultrasound devices to surgical instruments and implants. The company has its own research and development departments working to develop new and improved products to meet the needs of patients and medical professionals. In the biotechnology segment, CPMC is engaged in the manufacturing of biologics and recombinant proteins. These products are used in the treatment of cancer, autoimmune diseases, and other serious conditions. The company is also working on developing new biotech therapies to meet future medical needs. Additionally, CPMC also offers a range of services, including logistics, distribution, and marketing. The company has a well-established distribution network that distributes its products throughout China. It also collaborates with international distribution partners to distribute its products on a global level. In recent times, CPMC has focused on integrating high-tech technologies such as artificial intelligence, big data, and cloud computing to enhance its research and development work and improve its products. Overall, CPMC has a strong track record as one of the leading companies in the Chinese pharmaceutical industry. It is committed to continuing to develop and produce innovative products to enhance the health and well-being of people worldwide. CPMC Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding CPMC Holdings's Return on Equity (ROE)

CPMC Holdings's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing CPMC Holdings's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

CPMC Holdings's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in CPMC Holdings’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about CPMC Holdings stock

What is the ROE (Return on Equity) of CPMC Holdings this year?

The ROE of CPMC Holdings this year is 0.09 undefined.

How has the Return on Equity (ROE) of CPMC Holdings developed compared to the previous year?

The ROE of CPMC Holdings has increased by -5.52% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of CPMC Holdings?

A high ROE indicates that CPMC Holdings generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of CPMC Holdings?

A low ROE can indicate that CPMC Holdings is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of CPMC Holdings affect the company?

A change in ROE (Return on Equity) of CPMC Holdings can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of CPMC Holdings?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of CPMC Holdings?

Some factors that can influence CPMC Holdings's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does CPMC Holdings pay?

Over the past 12 months, CPMC Holdings paid a dividend of 0.24 CNY . This corresponds to a dividend yield of about 3.87 %. For the coming 12 months, CPMC Holdings is expected to pay a dividend of 0.25 CNY.

What is the dividend yield of CPMC Holdings?

The current dividend yield of CPMC Holdings is 3.87 %.

When does CPMC Holdings pay dividends?

CPMC Holdings pays a quarterly dividend. This is distributed in the months of July, October, June, October.

How secure is the dividend of CPMC Holdings?

CPMC Holdings paid dividends every year for the past 16 years.

What is the dividend of CPMC Holdings?

For the upcoming 12 months, dividends amounting to 0.25 CNY are expected. This corresponds to a dividend yield of 4.04 %.

In which sector is CPMC Holdings located?

CPMC Holdings is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von CPMC Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CPMC Holdings from 9/25/2023 amounting to 0.133 CNY, you needed to have the stock in your portfolio before the ex-date on 9/4/2023.

When did CPMC Holdings pay the last dividend?

The last dividend was paid out on 9/25/2023.

What was the dividend of CPMC Holdings in the year 2023?

In the year 2023, CPMC Holdings distributed 0.254 CNY as dividends.

In which currency does CPMC Holdings pay out the dividend?

The dividends of CPMC Holdings are distributed in CNY.